Engage Bio Acquired by Lilly to Accelerate Development of Non-Viral Genetic Medicines
Engage Biologics Inc. (“Engage”), a preclinical biotechnology company pioneering non-viral DNA delivery, today announced that it has been acquired by Eli Lilly and Company (“Lilly”).
